Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

AKBA Q3 2016 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$375M

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$31M

Operating Income

-$36M

Net Income

-$36M

EPS (Diluted)

$-0.96

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$169M

Total Liabilities

$68M

Stockholders' Equity

$101M

Cash & Equivalents

$66M

← FY 2016 All Quarters Q4 2016 →